Jermo Johannes van Toor

1PUBLICATIONS
0CO-AUTHORS
Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 31, 2020
Mepolizumab add-on therapy in a real world cohort of patients with severe eosinophilic asthma: response rate, effectiveness, and safety.

Jermo Johannes van Toor, Sophie C van der Mark, Jasper H Kappen

Pageof 1

Frequent Collaborators